A network meta-analysis of the discontinuation of blood-pressure (BP)-lowering medications due to adverse drug effects (AEs) found that the best-tolerated treatment was a combination of an angiotensin ...

FDA's Adam Fisher speaks at the 2026 REdI meeting. (Source: REdI) Adam Fisher, the staff director of the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research (CDER) at the ...

Right after reporting a major Phase 3 LAG-3 miss that has rattled analysts, Regeneron Pharmaceuticals revealed a back-loaded partnership with Parabilis Medicines aimed at adding a new drug class to ...

The FDA has approved AstraZeneca’s Baxfendy to treat uncontrolled hypertension, marking the first approval for an aldosterone synthase inhibitor in the indication. Baxfendy, also known as baxdrostat, ...

A Texas couple whose son died of an overdose in 2025 after using OpenAI's ChatGPT tool to get information about drugs sued the technology company on Tuesday, blaming the AI platform for his death.

Tennessee is moving forward with clinical trials of ibogaine, a controversial psychedelic drug recently fast-tracked for research under an executive order signed by President Donald Trump. Tennessee ...

Eli Lilly LLY1.86%increase; up pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA-1.39%decrease; down pointing triangle founder Jensen Huang earlier this year in San Francisco ...

Stroke remains a leading cause of mortality and disability worldwide, requiring timely therapeutic decisions. Existing content-based drug recommendation approaches often rely on static similarity ...

The Trump administration is proposing wastewater testing on a national level to try to ferret out data on illegal drug use in real time, according to a draft of a new drug control strategy obtained by ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. New data shows major differences across the United States in drug use, ...